Definition: inherited genetic disorder characterized by the impaired metabolism of deoxyadenosine during DNA breakdown

Epidemiology


Etiology


Pathophysiology

  • Defect in Adenosine Deaminase (ADA) enzyme involved in the purine salvage pathway.
  • Mechanism of Toxicity:
    • ADA normally deaminates adenosine inosine.
    • Deficiency leads to accumulation of adenosine and deoxyadenosine (dATP) within cells.
    • ↑ dATP inhibits ribonucleotide reductase.
    • Result: Impaired DNA synthesis toxicity and apoptosis of rapidly dividing cells, specifically lymphocytes.
  • Leads to Severe Combined Immunodeficiency (SCID) (2nd most common cause after X-linked IL-2R -chain defect).


Clinical features

  • Presents in infancy with Failure to Thrive (FTT).
  • Chronic diarrhea and recurrent, severe infections.
  • Susceptibility to all pathogen types due to lack of both humoral (B-cell) and cell-mediated (T-cell) immunity:
    • Fungal: Oral thrush (Candida), Pneumocystis jirovecii pneumonia.
    • Viral: CMV, VZV, HSV, RSV.
    • Bacterial: Otitis media, pneumonia, sepsis.
    • Protozoal: CryptosporidiumGiardia.

Diagnostics

  • CBC: Profound lymphopenia (↓ T cells and ↓ B cells).
  • CXR: Absent thymic shadow (also seen in DiGeorge syndrome).
  • Flow Cytometry: Absent/low CD3+ (T cells) and CD19+ (B cells).
  • Newborn Screening: Detected via T-cell receptor excision circles (TRECs).

Treatment